Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy
安罗替尼联合奥沙利铂和卡培他滨作为一线疗法治疗RAS/BRAF野生型转移性结直肠腺癌患者的II期研究
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-022-02357-6
Liu, Yue; Xiao, Qian; He, Jinjie; Hu, Hanguang; Du, Jinlin; Zhu, Yuping; Chen, Jiaqi; Liu, Zhuo; Wang, Jianping; Sun, Lifeng; Xu, Dong; Li, Jun; Liao, Xiujun; Wang, Jianwei; Cai, Yibo; Cai, Cheng; Jin, Zhekang; Wang, Liuhong; Yuan, Ying; Ding, Kefeng